Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization-Reference-Cited by-同舟云学术

Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization

Published:2022-03-17 Issue:7 Volume:239 Page:2215-2232
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Nirogi Ramakrishna,Abraham Renny,Jayarajan Pradeep,Goura Venkatesh,Kallepalli Rajesh,Medapati Rajesh babu,Tadiparthi Jayaprakash,Goyal Vinod kumar,Pandey Santosh kumar,Subramanian Ramkumar,Petlu Surendra,Thentu Jagadeesh Babu,Palacharla Veera Raghava Chowdary,Gagginapally Shankar Reddy,Mohammed Abdul Rasheed,Jasti Venkat

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s00213-022-06108-6.pdf

Reference70 articles.

1. Aboul-Fotouh S (2015) Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters. Psychopharmacology 232(6):1095–1105

2. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington, VA

3. Andreasen JT, Redrobe JP (2009) Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests. Behav Brain Res 197:150–156

4. Awtry TL, Frank JG, Werling LL (2006) In vitro regulation of serotonin transporter activity by protein kinase A and nicotinic acetylcholine receptors in the prefrontal cortex of rats. Synapse 59(6):342–349

5. Bahr R, Lopez A, Rey JA (2019) Intranasal Esketamine (SpravatoTM) for use in treatment-resistant depression in conjunction with an oral antidepressant. Pharmacy and Therapeutics 44:340

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The need for guidance in antidepressant drug development: Revisiting the role of the forced swim test and tail suspension test;Regulatory Toxicology and Pharmacology;2024-08

2. Discovery of a Novel Class of Benzimidazole-Based Nicotinic Acetylcholine Receptor Modulators: Positive and Negative Modulation Arising from Overlapping Allosteric Sites;Journal of Medicinal Chemistry;2023-08-31

3. Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors;Pharmacological Research;2023-08

4. Pathophysiology of nAChRs: Limbic circuits and related disorders;Pharmacological Research;2023-05

5. Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects;Clinical Drug Investigation;2022-08-13